Novel Assay Using Total Hepatitis C Virus (HCV) Core Antigen quantification for Diagnosis of HCV Infection in Dialysis Patients

Dialysis patients remain a high-risk group for hepatitis C virus (HCV) infection. The current diagnosis of HCV infection among dialysis patients includes serological assays and nucleic acid amplification technology (NAT) for assessing serum anti-HCV antibody and HCV viremia, respectively. However, c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Microbiol
Hlavní autoři: Fabrizi, Fabrizio, Lunghi, Giovanna, Aucella, Filippo, Mangano, Stefano, Barbisoni, Francesco, Bisegna, Sergio, Vigilante, Domenico, Limido, Aurelio, Martin, Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2005
Témata:
Virology
On-line přístup:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC540167/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15635003/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.43.1.414-420.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky